TIPRL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.167800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.145000E-01
Normal-vs-Stage2
7.871200E-01
Normal-vs-Stage3
6.671200E-01
Normal-vs-Stage4
3.969200E-01
Stage1-vs-Stage2
8.384600E-01
Stage1-vs-Stage3
5.869600E-01
Stage1-vs-Stage4
3.421400E-01
Stage2-vs-Stage3
3.739800E-01
Stage2-vs-Stage4
1.642390E-01
Stage3-vs-Stage4
2.443600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.743800E-01
Normal-vs-AfricanAmerican
3.644600E-01
Normal-vs-Asian
5.874800E-01
Caucasian-vs-AfricanAmerican
5.193200E-01
Caucasian-vs-Asian
3.096800E-01
AfricanAmerican-vs-Asian
9.152200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.134800E-01
Normal-vs-Female
8.151200E-01
Male-vs-Female
9.083600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.318200E-01
Normal-vs-Age(41-60Yrs)
5.360800E-01
Normal-vs-Age(61-80Yrs)
9.477600E-01
Normal-vs-Age(81-100Yrs)
8.051600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.142200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.989200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.370800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.204100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.219200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.158000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.878200E-01
Normal-vs-Daily Drinker
4.014000E-01
Normal-vs-Weekly Drinker
8.379600E-01
Normal-vs-Occasional Drinker
4.288800E-01
Normal-vs-Social Drinker
7.363400E-01
Non Drinker-vs-Daily Drinker
6.670100E-02
Non Drinker-vs-Weekly Drinker
9.101000E-01
Non Drinker-vs-Occasional Drinker
2.908600E-01
Non Drinker-vs-Social Drinker
6.979200E-01
Daily Drinker-vs-Weekly Drinker
8.296400E-02
Daily Drinker-vs-Occasional Drinker
3.144400E-03
Daily Drinker-vs-Social Drinker
4.631900E-02
Weekly Drinker-vs-Occasional Drinker
4.042400E-01
Weekly Drinker-vs-Social Drinker
8.114200E-01
Occasional Drinker-vs-Social Drinker
5.871200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.881980E-01
Normal-vs-Grade 2
2.135700E-02
Normal-vs-Grade 3
3.657900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.941300E-03
Grade 1-vs-Grade 3
9.759200E-03
Grade 1-vs-Grade 4
1.881980E-01
Grade 2-vs-Grade 3
4.837200E-01
Grade 2-vs-Grade 4
2.135700E-02
Grade 3-vs-Grade 4
3.657900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.136200E-01
Normal-vs-NonDiabetic
8.053800E-01
Diabetic-vs-NonDiabetic
2.647800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.710200E-01
Normal-vs-NoPancreatitis
8.475400E-01
Pancreatitis-vs-NoPancreatitis
6.583600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.757800E-01
Normal-vs-N1
8.528600E-01
N0-vs-N1
3.300400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.141400E-01
Normal-vs-TP53-NonMutant
8.399600E-01
TP53-Mutant-vs-TP53-NonMutant
4.962000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
